In a recent study published in the iScience journal, researchers assessed the efficiency of immunization with a bacterial peptide conjugated to the severe acute respiratory syndrome coronavirus 2 ...

IT has recently been observed 1 that the carrier weights, that is, the weight of protein carrying one gram–equivalent of prosthetic group, of a class of conjugated proteins, the chromoproteins, is in ...

KLOSTERNEUBURG, Austria & ROCKVILLE, Md.--(BUSINESS WIRE)--VALANX Biotech (VALANX), a biotech company developing novel technology for site-specific protein conjugation in drug and diagnostics ...

Physician-scientists in the Cancer Center at Children's Hospital of Philadelphia (CHOP) have developed a preclinical, potent therapy attached to an antibody that targets a surface protein expressed in ...

ROSEMONT, Ill.--(BUSINESS WIRE)--Proteintech, the benchmark in antibodies and proteins, announces the launch of over 500 antibodies directly conjugated with high-performance CoraLite®488 and ...

Researchers from Elpiscience Biopharmaceuticals Inc. discussed the discovery and preclinical characterization of a novel NKG2A antibody-IL-2 mutant fusion protein – ES-015.129 – being developed as ...

Researchers from MD Anderson Cancer Center recently presented the discovery and preclinical evaluation of LLO-CD47, a novel protein-antibody conjugate linking anti-CD47 to Listeriolysin O (LLO), a ...

Most of our prior work focused on the Ubl protein SUMO as it is essential in budding yeast and its conjugation to substrates requires an enzyme cascade that involves fewer factors in comparison to the ...

Large biomolecules such as immunoglobulin M, immunoglobulin A, virus-like particles (VLPs), plasma proteins, and polyethylene glycol (PEG)-conjugated proteins are difficult to purify because of their ...

Synta Pharmaceuticals Corp. SNTA +1.24% today announced the launch of its Hsp90-inhibitor Drug Conjugate (HDC) platform, which leverages the Company's expertise in chaperone biology and medicinal ...

Researchers at The Wistar Institute have engineered a small-molecule drug conjugate that has directed an Aurora kinase A inhibitor into tumours via heat shock protein 90 targeting, increased ...